Prot #NC-6004-008: Phase I/II Clinical Trial of NC-6004 in Combination with 5-FU and Cetuximab as First-line Treatment in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of The Head and Neck

  • Matsangou, Maria (PD/PI)

Project: Research project

Project Details

Effective start/end date10/10/1710/10/20


  • PPD Investigator Services, LLC (Prot #NC-6004-008 // Prot #NC-6004-008)
  • NanoCarrier Co., Ltd. (Prot #NC-6004-008 // Prot #NC-6004-008)